| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06403943 | Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis | Adjuvant | Recruiting |
| Phase 3 | |||
| NCT06081361 | Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin… | Pulmonary Tuberculosis | Active, Not Recruiting |
| NCT07268664 | Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant… | Rifampicin Resistant Tuberculosis | Not Yet Recruiting |
| Phase 2 | |||
| NCT06764368 | Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary… | Neuroendocrine Tumors | Not Yet Recruiting |
| NCT06809413 | Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium… | Fluoroquinolone | Enrolling by Invitation |
| NCT07372781 | Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium… | Monotherapy | Enrolling by Invitation |
| Phase 1/2 | |||
| NCT06811012 | Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis | Tuberculosis | Enrolling by Invitation |
| NCT06811025 | Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis | Tuberculosis | Enrolling by Invitation |
| Not specified | |||
| NCT07607288 | Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect… | Therapeutic Drug Monitoring (TDM) | Enrolling by Invitation |
| NCT07615309 | To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of… | Mycobacterium Abscessus Infection | Enrolling by Invitation |